Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4796490
Max Phase: Preclinical
Molecular Formula: C24H39N5O13
Molecular Weight: 605.60
Molecule Type: Unknown
Associated Items:
ID: ALA4796490
Max Phase: Preclinical
Molecular Formula: C24H39N5O13
Molecular Weight: 605.60
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](COc4ccc([N+](=O)[O-])cc4)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C24H39N5O13/c25-6-12-16(31)18(33)19(34)24(39-12)42-22-11(27)5-10(26)21(20(22)35)41-23-17(32)14(28)15(30)13(40-23)7-38-9-3-1-8(2-4-9)29(36)37/h1-4,10-24,30-35H,5-7,25-28H2/t10-,11+,12-,13-,14+,15-,16-,17-,18+,19-,20-,21+,22-,23-,24-/m1/s1
Standard InChI Key: UWAABXLJFCBPEX-OSMKSXLKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 605.60 | Molecular Weight (Monoisotopic): 605.2544 | AlogP: -5.30 | #Rotatable Bonds: 9 |
Polar Surface Area: 314.75 | Molecular Species: BASE | HBA: 17 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.05 | CX Basic pKa: 9.54 | CX LogP: -4.79 | CX LogD: -10.21 |
Aromatic Rings: 1 | Heavy Atoms: 42 | QED Weighted: 0.09 | Np Likeness Score: 0.82 |
1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT. (2020) Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels., 203 [PMID:32679454] [10.1016/j.ejmech.2020.112602] |
Source(1):